Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2008

Conditions

Mantle Cell Lymphoma

Interventions

DRUG

Adriblastin

DRUG

dexamethasone

DRUG

Chlorambucil

DRUG

rituximab

DRUG

cyclophosphamide

DRUG

alkeran

PROCEDURE

Total body irradiation (8Gy/4fr)

DRUG

vincristine

0,4 mg/day day 1 to day 4

Trial Locations (3)

Regional university hospital, Besançon

Regional university hospital, Rennes

REgional Hospital, Tours

All Listed Sponsors

collaborator

Hoffmann-La Roche

INDUSTRY

lead

French Innovative Leukemia Organisation

OTHER

NCT00285389 - Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years | Biotech Hunter | Biotech Hunter